Evidence map›Paper›PMID 32804924›Full record

ArticlePLoS computational biology2020

A Bayesian phylogenetic hidden Markov model for B cell receptor sequence analysis.

Amrit Dhar, Duncan K Ralph, Vladimir N Minin, Frederick A Matsen

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Amrit DharDepartment of Statistics, University of Washington, Seattle, Washington, United States of America.
Duncan K RalphComputational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.ORCID 0000-0002-2527-8610
Vladimir N MininDepartment of Statistics, University of California, Irvine, California, United States of America.ORCID 0000-0002-1917-9288
Frederick A MatsenComputational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.ORCID 0000-0003-0607-6025
Fred Hutch Cancer Center · USUniversity of California, Irvine · USUniversity of Washington · US

Funding

Systems Biology CoreU19AI128914 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KENNETH D STUART · 2017 to 2026
$29.5M
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathwaysR01AI138709 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2018 to 2022
$5.0M
DEFINING THE INFANT IMMUNE RESPONSE TO HIVR01AI120961 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2016 to 2020
$4.1M
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptorsR01AI146028 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2019 to 2024
$3.4M
Leveraing deep sequencing data to understand antibody maturationR01GM113246 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2014 to 2018
$1.9M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI120961NIAID NIH HHS R01 AI138709NIAID NIH HHS R01 AI146028NIAID NIH HHS U19 AI128914NIGMS NIH HHS R01 GM113246
6 · The paper itself

Abstract

The human body generates a diverse set of high affinity antibodies, the soluble form of B cell receptors (BCRs), that bind to and neutralize invading pathogens. The natural development of BCRs must be understood in order to design vaccines for highly mutable pathogens such as influenza and HIV. BCR diversity is induced by naturally occurring combinatorial "V(D)J" rearrangement, mutation, and selection processes. Most current methods for BCR sequence analysis focus on separately modeling the above processes. Statistical phylogenetic methods are often used to model the mutational dynamics of BCR sequence data, but these techniques do not consider all the complexities associated with B cell diversification such as the V(D)J rearrangement process. In particular, standard phylogenetic approaches assume the DNA bases of the progenitor (or "naive") sequence arise independently and according to the same distribution, ignoring the complexities of V(D)J rearrangement. In this paper, we introduce a novel approach to Bayesian phylogenetic inference for BCR sequences that is based on a phylogenetic hidden Markov model (phylo-HMM). This technique not only integrates a naive rearrangement model with a phylogenetic model for BCR sequence evolution but also naturally accounts for uncertainty in all unobserved variables, including the phylogenetic tree, via posterior distribution sampling.

Indexed as

Models, GeneticReceptors, Antigen, B-CellBayes TheoremComputational BiologyGene Rearrangement, B-LymphocyteHumansMarkov ChainsPhylogenySequence Analysis, DNASomatic Hypermutation, ImmunoglobulinVaccinesReceptors, Antigen, B-CellVaccines

Identifiers

PMID32804924
PMCPMC7451993
OpenAlexW2954842515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.